Assessment of the Safety and Efficacy of Dupilumab in Children With Asthma (Liberty Asthma Excursion)

NCT03560466 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

378

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Dupilumab (SAR231893/REGN668)
DRUG: Asthma controller therapies (incl. prednisone/prednisolone)
DRUG: Asthma reliever therapies

Sponsor

Sanofi

Collaborators

[object Object]